your market intelligence analyst
Search Results
Edit Save
319 results
DRG Blog 10/15/2019 03:01
Building an analytics engine capable of mastering and integrating large data sets to solve for knotty business questions is an enormous challenge for life sciences companies. But those that have managed to build the engine often find the next step -- turning the analytics generated into actionable insights that drive results – an equally tall […]. .
DRG Blog 10/11/2019 11:07
Does results from CheckMate-459 challenge the position of other immune checkpoint inhibitors in the hepatocellular carcinoma treatment landscape? The annual meeting of the European Society of Medical Oncology (ESMO) held in Barcelona, Spain from 27 Sep - 01 Oct 2019 shed light on the results from the CheckMate-459 hepatocellular carcinoma trial. Currently, Bayer Healthcare’s Nexavar […]. .
DRG Blog 10/04/2019 09:34
The WHO recently published an updated version of its list of essential medicine and diagnostics. The first WHO essential Medicines List, published in 1977, was a needed revolution in healthcare as it helped establish that medicines fulfilling unmet needs are essential yet remain inaccessible to too many. Since then, the list has been updated every […]. .
DRG Blog 10/03/2019 14:58
What ESMO 2019 announcements mean for the future of the ovarian cancer market and patient care PARP inhibitors have shown extremely encouraging data that could help pave the way for an entirely new treatment algorithm in ovarian cancer. These agents have given patients the opportunity for more effective treatments in the frontline and recurrent settings. […]. .
DRG Blog 10/01/2019 10:44
Effective Oct. 1, 2019, UnitedHealthcare will be adding utilization criteria for Avastin and Herceptin for members under commercial and community health plans. United is adding a requirement that patients use the biosimilars Kanjinti and Mvasi prior to using the original cancer drugs. Mvasi (bevacizumab-awwb) is the first FDA-approved biosimilar to Avastin (bevacizumab) for the treatment of […]. .
DRG Blog 10/01/2019 06:25
Recently, there’s been a lot of buzzy talk about “building the data lake,” with some companies trying to build out and manage massive internal “raw” data stores. That’s great as far as it goes, but these efforts often suffer from a set of faulty underlying assumptions – namely, that data is scarce (it’s not) and […]. .
DRG Blog 09/27/2019 13:18
What are limited distribution drugs? “Limited distribution drug” status is generally assigned to specialty medications with complex regimens to manage. These drugs are expensive, accounting for around 45 percent of the pharmacy drug spend per Express Scripts’ 2018 drug trend report, and require special handling, administration, or monitoring. The therapy areas with the highest number […]. .
DRG Blog 09/26/2019 08:35
Takeaways from the Philips Digital Health Conclave 2019 Unique challenges require unique solutions, and recent advancements in digital healthcare capabilities are increasingly enabling healthcare companies and providers to create tailored solutions to various issues that are specific to particular localities and populations in an efficient and cost-effective manner.
DRG Blog 09/20/2019 10:34
Pharma rep visits have plunged, and non-personal promotion isn’t making up the gap We’ve been talking about rep automation and remote communication between reps and physicians for years (live and recorded/on-demand webinars, remote details, chatbots, etc.), because we know that as physicians grow ever-more time crunched and increasingly face employer restrictions on interacting with reps, [...]. .
DRG Blog 09/20/2019 00:40
Like the pharmaceutical industry as a whole, the market research and business intelligence functions within have experienced a tremendous transformation over the years—and continue to change. With increasing pressure on resources, heightened competition, and growing complexity of the market landscape, market researchers and the teams the support often need to do more with less, deliver […]. .
DRG Blog 09/16/2019 10:23
In collecting our thoughts for a white paper about how life sciences companies can achieve next-level data applications, we found ourselves debating a confounding question: Are there any pharma or medtech manufacturers using data in a way that their peer companies in other industries – say, finance, retail or technology – would recognize as mature?
DRG Blog 08/28/2019 09:07
Heatmap messaging analysis is based on physicians’ ratings of the usefulness of content offerings across owned and earned channels. Physicians rated each type of information or service based on how useful it is in each channel. Pharma websites Deepen engagement with educational content beyond core product needs (prescribing/doing, trial results). 44% of HCPs value disease […]. .
DRG Blog 08/19/2019 08:09
Several new state drug pricing transparency laws were passed this year that will require life sciences companies to consider compliance responses now. Reporting requirements differ from state-to-state and failure to report may result in monetary penalties. Over the past several years, states have been steadily churning out bills focused on elements of health system pricing […]. .

Health Care

Health and Wellness

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies


Information Technologies

Job Titles

Legal and Regulatory

Political Entities


Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications